MPox is endemic in DRC, and has continued to cause large numbers of cases in the WHO African Region. In April, 2025, the WHO has restated that MPox continues to be a Public Health Emergency of ...

The FDA did not respond to a request for comment. U.S. Health Secretary Robert F. Kennedy Jr. has said that the agency's ...

Some U.S. biotech companies are considering moving early-stage trials of new medicines outside the United States as worry ...

Cytokinetics' PDUFA date for aficamten was extended to December 26th of 2025, due to the FDA's need to review a submitted ...

The United States is advising travellers aged 60 and up to hold off on getting the chikungunya vaccine while it looks into ...

Aurobindo Pharma's CuraTeQ Biologics receives marketing authorization for Zefylti filgrastim biosimilar in the UK and EU.

EMERYVILLE, Calif. , May 13, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA), the biotech royalty aggregator ...

Ireland’s Health and Safety Executive has criticised a new report revealing the country’s shocking last place in Western Europe for new oncology drug access.

Retail chatter around Moleculin Biotech surged on Monday after the company said the European Medicines Agency had approved ...

Antibiotic use in the first 3 month of life was associated with a 23% increase in risk of early puberty in girls.

New research reveals the potential of drugs that have been on the market for decades to treat diseases other than those for ...

Reports of severe adverse events in some people who received the chikungunya vaccine have spurred regulators in Europe and ...